Literature DB >> 10887558

[Determination of the minimum inhibitory concentration of fluconazole against Cryptococcus neoformans].

C M Fernández Andreu1, T Pimentel Turino, G Martínez Machín, M González Miranda.   

Abstract

The minimum inhibitory concentration of fluconozole was determined in 36 strains of Cryptococcus neoformans var. neoformans by a casitone broth microdilution method, taking into account that it is one of the most used antifungal agents in our country for the treatment of cryptococcal meningitis, the second opportunistic mycosis in order of frequency and that with the highest lethality among AIDS patients. The minimum inhibitory concentration of the studied strains ranged 0.125 to more than 64 micrograms/mL for a geometrical mean of 2.38 micrograms/mL. 50% of the strains were inhibited with 4 micrograms/mL and the least concentration that inhibited 90% was 16 micrograms/mL. It is stressed the importance of continuing this type of in vitro studies to detect the appearance of resistance of C. neoformans to antifungal agents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10887558

Source DB:  PubMed          Journal:  Rev Cubana Med Trop        ISSN: 0375-0760


  3 in total

1.  Fluconazole plasma concentration measurement by liquid chromatography for drug monitoring of burn patients.

Authors:  Silvia Regina Cavani Jorge Santos; Edvaldo Vieira Campos; Cristina Sanches; David Souza Gomez; Marcus Castro Ferreira
Journal:  Clinics (Sao Paulo)       Date:  2010-02       Impact factor: 2.365

Review 2.  Cryptococcus neoformans and Cryptococcus gattii Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group.

Authors:  Carolina Firacative; Wieland Meyer; Elizabeth Castañeda
Journal:  J Fungi (Basel)       Date:  2021-04-09

Review 3.  The status of cryptococcosis in Latin America.

Authors:  Carolina Firacative; Jairo Lizarazo; María Teresa Illnait-Zaragozí; Elizabeth Castañeda
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-04-05       Impact factor: 2.743

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.